Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Gordon

Showing results (311-320 of 327) with videos related to

Pageof 33
Sort By:
Transplantation Proceedings|February 1, 1987
OKT3 in the reversal of acute hepatic allograft rejectionC O Esquivel, J J Fung, B Markus, et al.
Transplantation|January 1, 1991
Liver transplantation in patients over sixty years of ageA C Stieber, R D Gordon, S Todo, et al.
Transplantation|January 1, 1991
The liver transplant waiting list--a single-center analysisR D Gordon, C M Hartner, A Casavilla, et al.
Transplantation Proceedings|February 1, 1987
Hepatic artery in liver transplantationS Todo, L Makowka, A G Tzakis, et al.
Alcoholism, Clinical and Experimental Research|April 1, 1989
Liver transplantation for alcoholic liver disease: a consideration of reasons for and againstD H Van Thiel, J S Gavaler, R E Tarter, et al.
Nephron|January 1, 1987
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejectionJ J Fung, A J Demetris, K A Porter, et al.
Transplantation Proceedings|October 1, 1994
Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipientsC R Gross, S K Savik, N L Ascher, et al.
Gastroenterology|May 1, 1988
Transplantation for primary biliary cirrhosisC O Esquivel, D H Van Thiel, A J Demetris, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
Journal of Human Hypertension|October 13, 2017
ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)S M C De Sousa, M Stowasser, J Feng, et al.
Pageof 33

Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
Transplantation Proceedings|February 1, 1987
OKT3 in the reversal of acute hepatic allograft rejectionC O Esquivel, J J Fung, B Markus, et al.
Transplantation|January 1, 1991
Liver transplantation in patients over sixty years of ageA C Stieber, R D Gordon, S Todo, et al.
Transplantation|January 1, 1991
The liver transplant waiting list--a single-center analysisR D Gordon, C M Hartner, A Casavilla, et al.
Transplantation Proceedings|February 1, 1987
Hepatic artery in liver transplantationS Todo, L Makowka, A G Tzakis, et al.
Alcoholism, Clinical and Experimental Research|April 1, 1989
Liver transplantation for alcoholic liver disease: a consideration of reasons for and againstD H Van Thiel, J S Gavaler, R E Tarter, et al.
Nephron|January 1, 1987
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejectionJ J Fung, A J Demetris, K A Porter, et al.
Transplantation Proceedings|October 1, 1994
Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipientsC R Gross, S K Savik, N L Ascher, et al.
Gastroenterology|May 1, 1988
Transplantation for primary biliary cirrhosisC O Esquivel, D H Van Thiel, A J Demetris, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
Journal of Human Hypertension|October 13, 2017
ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)S M C De Sousa, M Stowasser, J Feng, et al.
Pageof 33